Adnan M. Dahdul, M.D. – FDA Inspection, Jun 20, 2024

Record Details

This FDA Inspection record concerns Adnan M. Dahdul, M.D., with an inspection on June 20, 2024, issued by the New England District Office, covering biologics.

Company: Adnan M. Dahdul, M.D.
Inspection Date: June 20, 2024
Product Type: Biologics
Office: New England District Office
People: Asia D. Clark (Issuing Officer)
Matthew C. Watson (Issuing Officer)

View Company Profile

ID · ef7a3297-fe97-4b3c-ad33-f56a0e5d835a

Inspection Facts

Inspection number: 1241805
FDA center: Biologics
Project area: Vaccines and Allergenic Products
Outcome: Form 483 issued

FDA Citations

21 CFR 312.60FD-1572, protocol compliance
21 CFR 312.62(b)Case history records- inadequate or inadequate
21 CFR 50.20Consent not obtained, exceptions do not apply

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Adnan M. Dahdul, M.D.

FDA Inspection

Adnan M. Dahdul, M.D.June 20, 2024